Botanix Pharmaceuticals Ltd

BOT

Company Profile

  • Business description

    Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.

  • Contact

    41 - 47 Colin Street
    Suite 3
    West PerthWA6005
    AUS

    T: +61 865552945

    https://www.botanixpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    1

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,456.2090.501.08%
CAC 407,770.48176.612.33%
DAX 4023,086.65589.672.62%
Dow JONES (US)41,352.13599.171.47%
FTSE 1008,596.3599.551.17%
HKSE22,504.68385.271.74%
NASDAQ17,976.17265.441.50%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,327.89179.291.48%
S&P 5005,691.1286.981.55%
S&P/ASX 2008,238.0092.401.13%
SSE Composite Index3,279.037.62-0.23%

Market Movers